Summit Creek Advisors LLC West Pharmaceutical Services Inc Transaction History

Summit Creek Advisors LLC

$778 Million
Q1 2024

A detailed history of Summit Creek Advisors LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Summit Creek Advisors LLC holds 1,093 shares of WST stock, worth $360,023. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,093

Previous 1,079 1.3%

Holding current value

$360,023

Previous $379,000 13.98%

% of portfolio

0.06%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$338.27 - $413.0 $4,735 - $5,782	14 Added 1.3%	1,093 $432,000
Q2 2023 Aug 09, 2023	BUY	$334.63 - $382.47 $334 - $382	1 Added 0.09%	1,079 $412,000
Q4 2022 Feb 10, 2023	BUY	$209.34 - $261.61 $1,884 - $2,354	9 Added 0.84%	1,078 $253,000
Q3 2022 Nov 01, 2022	SELL	$246.08 - $343.65 $188,743 - $263,579	-767 Reduced 41.78%	1,069 $263,000
Q2 2022 Aug 11, 2022	BUY	$280.61 - $420.45 $7,857 - $11,772	28 Added 1.55%	1,836 $555,000

Q1 2022 May 09, 2022	BUY	$357.49 - $445.92 $3,574 - $4,459	10 Added 0.56%	1,808 $743,000
Q4 2021 Feb 10, 2022	BUY	$402.25 - $471.34 $1,609 - $1,885	4 Added 0.22%	1,798 $843,000
Q3 2021 Nov 08, 2021	BUY	$363.01 - $468.47 $163,354 - $210,811	450 Added 33.48%	1,794 $762,000
Q1 2021 Apr 20, 2021	BUY	$257.29 - $307.53 $96,226 - $115,016	374 Added 38.56%	1,344 $379,000
Q4 2020 Jan 20, 2021	SELL	$261.16 - $301.66 $767,810 - $886,880	-2,940 Reduced 75.19%	970 $275,000
Q3 2019 Oct 16, 2019	BUY	$121.41 - $150.02 $474,713 - $586,578	3,910 New	3,910 $555,000

Others Institutions Holding WST

# of Institutions

824

Shares Held

64.4M

Call Options Held

184K

Put Options Held

312K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.4B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Creek Advisors LLC with notifications on news.

Account

Summit Creek Advisors LLC West Pharmaceutical Services Inc Transaction History